The Yield of thoracoscopic biopsy truenat in the diagnosis of tuberculous pleural effusion

T. Kurian, A. Paramez, Rohitash Chandra, Nimmy Jose
{"title":"The Yield of thoracoscopic biopsy truenat in the diagnosis of tuberculous pleural effusion","authors":"T. Kurian, A. Paramez, Rohitash Chandra, Nimmy Jose","doi":"10.4103/jalh.jalh_7_20","DOIUrl":null,"url":null,"abstract":"Background and Objective: Extrapulmonary tuberculosis (EPTB) affects about 25% of patients presenting with Tuberculosis (TB). Tuberculous pleural effusion is the second-most common type of EPTB, after lymph node TB. Although the molecular TB diagnostics have lower turnaround time compared to traditional testing methods, the sensitivity in microscopy negative specimens are low. Higher cost and infrastructure requirements are other disadvantages. Truenat, developed by Mobilio diagnostics and validated by ICMR, is a rapid, polymerase chain reaction (PCR)-based diagnostic test to detect Mycobacterium Tuberculosis (MTB) and also rifampicin resistance. According to the WHO, the accuracy of Truenat is comparable to Xpert PCR. We report our experience in using Truenat for EPTB, specifically, pleural TB. Methods: We retrospectively analyzed data from thoracoscopy over the past 2 years. All data pertaining to the use of Truenat for TB in pleural fluid and thoracoscopic biopsy specimens, histopathology, and mycobacterial cultures were analyzed. Results: We had a total of 114 patients with undiagnosed pleural effusion who underwent thoracoscopy during the study. Forty-five patients (39%) had a diagnosis of TB, among the total 114 patients. The sensitivity of tissue Truenat was 51.11 (95% confidence interval [CI]: 35.77–66.30), tissue culture 37.50% (95% CI: 22.73–54.20), pleural fluid Truenat 20% (95% CI: 8.44–36.94), and fluid culture 14.29% (95% CI: 5.43–28.54). The specificities of all the confirmatory tests were 100% when compared to a reference standard which was taken as a combination of histology and culture as the reference standard with or without acid-fast bacilli in the histology samples. Tissue Truenat was significantly more sensitive than fluid Truenat (P < 0.05). Likewise, tissue culture was more sensitive than fluid culture (P < 0.05). Among all microbiology confirmatory tests performed, Truenat of pleural tissue had the highest yield (51.11). Conclusion: Thoracoscopic pleural biopsy Truenat results in improved sensitivity in cases of EPTB.","PeriodicalId":402083,"journal":{"name":"Journal of Advanced Lung Health","volume":"97 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Lung Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jalh.jalh_7_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background and Objective: Extrapulmonary tuberculosis (EPTB) affects about 25% of patients presenting with Tuberculosis (TB). Tuberculous pleural effusion is the second-most common type of EPTB, after lymph node TB. Although the molecular TB diagnostics have lower turnaround time compared to traditional testing methods, the sensitivity in microscopy negative specimens are low. Higher cost and infrastructure requirements are other disadvantages. Truenat, developed by Mobilio diagnostics and validated by ICMR, is a rapid, polymerase chain reaction (PCR)-based diagnostic test to detect Mycobacterium Tuberculosis (MTB) and also rifampicin resistance. According to the WHO, the accuracy of Truenat is comparable to Xpert PCR. We report our experience in using Truenat for EPTB, specifically, pleural TB. Methods: We retrospectively analyzed data from thoracoscopy over the past 2 years. All data pertaining to the use of Truenat for TB in pleural fluid and thoracoscopic biopsy specimens, histopathology, and mycobacterial cultures were analyzed. Results: We had a total of 114 patients with undiagnosed pleural effusion who underwent thoracoscopy during the study. Forty-five patients (39%) had a diagnosis of TB, among the total 114 patients. The sensitivity of tissue Truenat was 51.11 (95% confidence interval [CI]: 35.77–66.30), tissue culture 37.50% (95% CI: 22.73–54.20), pleural fluid Truenat 20% (95% CI: 8.44–36.94), and fluid culture 14.29% (95% CI: 5.43–28.54). The specificities of all the confirmatory tests were 100% when compared to a reference standard which was taken as a combination of histology and culture as the reference standard with or without acid-fast bacilli in the histology samples. Tissue Truenat was significantly more sensitive than fluid Truenat (P < 0.05). Likewise, tissue culture was more sensitive than fluid culture (P < 0.05). Among all microbiology confirmatory tests performed, Truenat of pleural tissue had the highest yield (51.11). Conclusion: Thoracoscopic pleural biopsy Truenat results in improved sensitivity in cases of EPTB.
胸腔镜活检对结核性胸腔积液的诊断价值
背景与目的:肺外结核(EPTB)影响约25%的结核病(TB)患者。结核性胸腔积液是继淋巴结结核之后第二常见的EPTB类型。虽然与传统检测方法相比,分子结核诊断的周转时间较短,但在显微镜阴性标本中的灵敏度较低。更高的成本和基础设施要求是其他缺点。Truenat由Mobilio诊断公司开发并经ICMR验证,是一种基于聚合酶链反应(PCR)的快速诊断检测试剂盒,用于检测结核分枝杆菌(MTB)和利福平耐药性。根据世界卫生组织,Truenat的准确性可与Xpert PCR相媲美。我们报告我们使用Truenat治疗EPTB的经验,特别是胸膜结核。方法:回顾性分析过去2年的胸腔镜检查资料。对胸膜液、胸腔镜活检标本、组织病理学和分枝杆菌培养中使用Truenat治疗结核病的所有数据进行了分析。结果:我们总共有114例未确诊的胸腔积液患者在研究期间接受了胸腔镜检查。在114名患者中,45名患者(39%)被诊断为结核病。组织Truenat敏感性为51.11(95%可信区间[CI]: 35.77 ~ 66.30),组织培养敏感性为37.50% (95% CI: 22.73 ~ 54.20),胸膜液Truenat敏感性为20% (95% CI: 8.44 ~ 36.94),液体培养敏感性为14.29% (95% CI: 5.43 ~ 28.54)。与组织标本中有无抗酸杆菌为对照标准,以组织与培养相结合的对照标准进行比较,所有验证试验的特异性均为100%。组织Truenat的敏感性显著高于液体Truenat (P < 0.05)。同样,组织培养比液体培养更敏感(P < 0.05)。在所有微生物学验证试验中,胸膜组织Truenat的产率最高(51.11)。结论:胸腔镜胸膜活检Truenat可提高EPTB的敏感性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信